AmerisourceBergen Corp. plans to settle a proposed class action by workers who say the pharmaceutical company’s retirement ...

In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive $300 million from an early settlement of some prepaid shares of Cencora along ...

But the latest Cencora stock sale comes a week after ... Walgreens began reducing its stake in the distributor, formerly known as AmerisourceBergen, and other businesses in the last four years ...

Cencora Inc., a Conshohocken-based wholesale drug distributor, scrubbed a diversity, equity, and inclusion page from its ...

Walgreens and Cencora have been working together since 2013, when the drug distributor was still known as AmerisourceBergen. But recently Walgreens has been winnowing its stake in Cencora as the ...

On an adjusted basis, Cencora, formerly known as AmerisourceBergen, reported first-quarter profit of $3.73 per share, compared to analysts' estimates of $3.50 per share. Sign up here. Wall Street ...

Cencora gave its full-year guidance a boost ... The drug wholesaler formerly known as AmerisourceBergen posted a profit of $488.6 million, or $2.50 a share, for the last three months of 2024.

AmerisourceBergen’s move into the digital health area is part of a revamp of the business, which will be renamed Cencora later this year to reflect a change in business strategy, with ...

in the EU and UK anticipated in calendar Q1 2025Strategic partnership with Cencora (formerly AmerisourceBergen) to support the planned commercial launches of LYTENAVA in UK and EU ISELIN ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global healthcare company, has significantly expanded the number and type of medications available in its sure supply program, a drug shortage ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on COR stock, giving a Buy rating on January 14. Ann Hynes has given her Buy rating due to a combination of factors ...

The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10%.